94 results on '"Clemmer J"'
Search Results
2. Management and outcomes for elderly women with vulvar cancer over time
3. Simulation of integrative physiology for medical education
4. Sorbent Augmented Dialysis Systems
5. History of Sorbents in Uremia
6. First Clinical Experience with an Adjunctive Hemoperfusion Device Designed Specifically to Remove β2-Microglobulin in Hemodialysis
7. The Role of Middle Molecules in Uremia - Preliminary Report of an International Survey of Nephrologists and Scientists
8. Rationale for Combined Hemoperfusion/Hemodialysis in Uremia
9. Patient, treatment and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer
10. Patterns of Care, Predictors and Outcomes of Chemotherapy for Uterine Serous Carcinoma: A population-based analysis
11. Patient, Treatment and Discharge Factors associated with Hospital Readmission within 30days after Surgery for Vulvar Cancer
12. Electrolytic Production of Hydrometallurgical Reagents for Processing Manganese Ores
13. Sorbent augmented dialysis systems
14. History of sorbents in uremia
15. The role of middle molecules in uremia--preliminary report of an international survey of nephrologists and scientists
16. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis
17. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis
18. Patient, Treatment and Discharge Factors associated with Hospital Readmission within 30 days after Surgery for Vulvar Cancer
19. CLINICAL RESULTS OF A SORBENT SYSTEM COMBINED WITH HIGH-FLUX DIALYSIS (HFD) TO REMOVE β2-MICROGLOBULIN (β2-M) IN ENDSTAGE RENAL DISEASE (ESRD)
20. Sorbent Augmented Dialysis Systems.
21. The Role of Middle Molecules in Uremia - Preliminary Report of an International Survey of Nephrologists and Scientists.
22. History of Sorbents in Uremia.
23. First Clinical Experience with an Adjunctive Hemoperfusion Device Designed Specifically to Remove β.
24. Rationale for Combined Hemoperfusion/Hemodialysis in Uremia.
25. BENEFICATION OF SOUTH CAROLINA SILLIMANITE SCHISTS *.
26. The Doctor Analyzed
27. Sorbent augmented dialysis systems
28. The role of middle molecules in uremia - Preliminary report of an international survey of nephrologists and scientists
29. Rationale for combined hemoperfusion/hemodialysis in uremia
30. ChemInform Abstract: REDUCTION OF THE BIS(2,9‐DIMETHYL‐1,10‐PHENANTHROLINE)COPPER(II) ION BY SUBSTITUTED HYDROQUINONES
31. ChemInform Abstract: COMPARISON OF THE ELECTRON-TRANSFER REACTIVITIES OF TRIS(OXALATO)COBALTATE(III) (CO(OX)33-) AND TRIS(1,10-PHENANTHROLINE)COBALT(III) (CO(PHEN)33+) WITH METALLOPROTEINS
32. ChemInform Abstract: SYNTHESIS AND CHARACTERIZATION OF THE (4-HYDROXYPHENYL PHOSPHATO)PENTAAMMINECOBALT(III) ION
33. Flotation
34. Flotation
35. Medical Practice Legislation for Benefit of Public.
36. Automania the New Disease.
37. CONVENTIONS.
38. Applications of radioisotope in metallurgical research
39. SOLVENT EXTRACTION SEPARATION OF URANIUM FROM ACID LEACH LIQUORS AND PULPS
40. SOLVENT EXTRACTION FOR RECOVERING URANIUM AND VANADIUM FROM SALT-ROAST- PROCESS SOLUTIONS
41. Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer.
42. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis.
43. Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis.
44. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
45. Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: analysis of the National Cancer Database.
46. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
47. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.
48. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population.
49. Trends in the treatment of uterine leiomyosarcoma in the Medicare population.
50. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.